2010
DOI: 10.2147/ijgm.s13013
|View full text |Cite
|
Sign up to set email alerts
|

Duodenal administered seal oil for patients with subjective food hypersensitivity: an explorative open pilot study

Abstract: Short-term duodenal administration of n-3 polyunsaturated fatty acid (PUFA)-rich seal oil may improve gastrointestinal complaints in patients with subjective food hypersensitivity, as well as joint pain in patients with inflammatory bowel disease (IBD). The aim of the present explorative pilot study was to investigate whether 10-day open treatment with seal oil, 10 mL self-administrated via a nasoduodenal tube 3 times daily, could also benefit nongastrointestinal complaints and quality of life (QoL) in patient… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
3
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 49 publications
1
3
0
Order By: Relevance
“…The patients in the present thesis also reported considerably impaired QoL. Unfortunately, we did not have a control group in this explorative, open study (paper II), but the baseline total sum score of the QoL (28.0) reported in the present thesis[152] is comparable with that reported in the study of Arslan and colleagues(27.4) [26], were the QoL of patients with SHC was significantly impaired compared to controls(13.5). Considering the patients' complex symptomatology, including both gastrointestinal and systemic symptoms, and the fact that their complaints often remain unexplained, impaired QoL was highly expected in the present thesis.…”
supporting
confidence: 66%
“…The patients in the present thesis also reported considerably impaired QoL. Unfortunately, we did not have a control group in this explorative, open study (paper II), but the baseline total sum score of the QoL (28.0) reported in the present thesis[152] is comparable with that reported in the study of Arslan and colleagues(27.4) [26], were the QoL of patients with SHC was significantly impaired compared to controls(13.5). Considering the patients' complex symptomatology, including both gastrointestinal and systemic symptoms, and the fact that their complaints often remain unexplained, impaired QoL was highly expected in the present thesis.…”
supporting
confidence: 66%
“…Twenty-six patients self-administered 10 ml seal oil three times daily for 10 days through a nasoduodenal feeding tube. Compared with baseline, gastrointestinal as well as non-gastrointestinal complaints and quality of life improved significantly, both at end of treatment and 1-month posttreatment [89]. The consistent improvements of systemic symptoms following seal oil administration warrant further placebo-controlled trials for confirmation of effect.…”
Section: Therapeutic Trials: Pilot Studies With Seal Oilmentioning
confidence: 83%
“…Interestingly, we have recently shown that joint and bodily pain is attenuated following enteral (tube) administration of seal oil to the duodenum (199). Systemic manifestations (co-morbidities) in subjective food hypersensitivity often regarded as psychiatric somatisation doesn't fit with a rapid (within 10 days') effect of seal oil administration, an effect supposed to be due to suppression of prostaglandin E 2 production by the administrated omega-3 PUFA.…”
Section: Role Of Psychological Factors (Paper V)mentioning
confidence: 99%